Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in t ...

Dynavax Technologies (NASDAQ:DVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. A number ...

MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 to ...

William Blair analyst Matt Phipps maintained a Hold rating on Kezar Life Sciences (KZR – Research Report) today. The company’s shares closed ...

To be successfully implemented, gamification should leverage technology, make learning experiential, sustainable, and ...

AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as a ...